The prevalence of anti-trans coverage (opens in new tab)
Yesterday in the comments section of a website I frequent, I defended legacy media. Someone has to pay for stories about the pulling of COVID vaccine efficacy data, or, to cite a much lauded example, the Miami Herald’s groundbreaking series on Jeffrey Epstein. Not much cited is the New York Times’ investigation into how France […]
Read the original article